Comparability protocol for 22.5 mg tablets (NADA # 141-526)

• Award Number: R01FD007800

• ORGANIZATION: FOOD AND DRUG ADMINISTRATION

• OPDIV: FDA

• AWARD CLASS: DISCRETIONARY

• AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

• PERIOD OF PERFORMANCE START DATE: 12/01/2022

• PERIOD OF PERFORMANCE END DATE: 11/30/2023